ORTEXORTEX News
Tracking HXL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HX
Earnings PreviewHXL

HXL Heads Into Q3 Print With Bears Retreating but Analysts Cautious

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 20 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

HXL reports Q3 results today with short sellers pulling back even as the analyst community trims price targets across the board.

The most striking feature of the positioning is the disconnect between short interest and options. Short interest has jumped roughly 39% over the past month to 5.8% of the free float, a meaningful build that reflects genuine skepticism about near-term delivery. Yet on the day of the print, the put/call ratio has spiked to 0.30, well above its 20-day average of 0.16 and about 1.3 standard deviations elevated. That single-session jump, from 0.07 the prior day, points to fresh demand for downside protection right at the open of earnings day. The borrow market, though, tells a different story: availability is loose at 658%, meaning there are more than six shares available to lend for every one currently shorted. Borrowing costs remain negligible at 0.53%. The lending market is not under any stress, even as the short position has grown.

Analysts have spent the past month moving one way only: down. Morgan Stanley cut its target to $97 on October 19, the day before the print, keeping an Equal-Weight rating. RBC Capital trimmed to $105 while holding Outperform. Wells Fargo, earlier bullish with a $120 target, has pulled that back to $105. The consensus mean now sits around $105, roughly 15% above the $91.61 close. Seaport Global stands out as the contrarian, upgrading to Buy at $104 on October 12. The bear case centres on concentration risk: 66% of revenue tied to commercial aerospace means any production slip from Airbus or Boeing on A350, 787 or 737 Max programs flows directly into fixed-cost absorption. The bull case rests on operating leverage at higher volumes, with management flagging roughly $500 million of incremental annual sales potential from existing contracts once wide-body production normalises, plus a defence segment growing at over 13% year-over-year. TD Cowen's $90 Hold target sits below the current price, making it the most pessimistic voice and a useful marker for what a bearish read on the print implies for the stock.

Institutional ownership gives some context for who is holding through the uncertainty. BlackRock added 1.34 million shares in the September quarter, lifting its stake to 18.8% of shares outstanding. T. Rowe Price added roughly 800,000 shares in the same period, now at 7.75%. Both are meaningful additions ahead of what has historically been a punishing earnings setup: the last two quarterly prints, in July 2026, produced one-day declines of 2.5% and 6.5% respectively. The five-day reactions were similarly negative both times, at roughly 2.5% and 5.2% lower. The stock has still gained 7.8% over the past week heading into today, suggesting some buyers are leaning against that recent pattern.

The print will test whether the volume signals from wide-body production schedules are translating into revenue in line with what remains a compressed but still elevated consensus, and whether management's margin guidance can justify a forward P/E of around 30 times after a month of analyst target reductions.

Stocks in this article

See the live data behind this article on ORTEX.

Open HXL on ORTEX →

How this article was generated

Generated
20 Oct 2026, 04:14
Data as of
20 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.